How would you assess your pain now, at this moment? 0. 1. 2. 3. 4. 5. 6. 7. 8. 9. 10 none max. How strong was the strongest pain during the past 4 weeks? 0. 1. The painDETECT questionnaire (PDQ) was originally designed to differentiate between pain phenotypes. with RA, PsA and SpA ( per diagnosis) were extracted from 'the DANBIO painDETECT study'. Download ePub. Adaptation, validity and reliability of the modified painDETECT questionnaire for patients with subacromial pain Epub Feb 6. Download full-text PDF.
|Language:||English, Spanish, French|
|Genre:||Academic & Education|
|Distribution:||Free* [*Registration Required]|
Objectives: We aimed to compare painDETECT scores in outpatients seen in a rheumatology department. epubBooks has free ebooks to download for Kindle or EPUB readers like iPad, iPhone, Android, Windows Phone, Nook and eReaders. Key Words: PainDETECT, neuropathic pain, knee osteoarthritis, .. where it is permissible to download and share the work provided it is properly cited.
Is an easy and reliable diagnosis of localized neuropathic pain LNP possible in general practice?
Development of a screening tool based on IASP criteria. Modelling hematological parameters after total body irradiation. Next-generation-sequencing-spectratyping reveals public T-cell receptor repertoires in pediatric very severe aplastic anemia and identifies a beta chain CDR3 sequence associated with hepatitis-induced pathogenesis.
New insights into disease-specific patterns of neuropathic pain symptoms using the painDETECT-questionnaire with a simple standardization procedure.
Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of high-risk patients including ethical aspects.
J Craniomaxillofac Surg. Eur J Orthod.
Aktuelle Urol. Application in comparison of AMH assays. J Orofac Orthop. Blood Cancer Journal 1, e8; doi Clin Chem; 56 Suppl. CCLM 47, A CCLM 47, Application in Assessment of Carry-Over.
Laryngoscope, — The analysis was directed at the seven items assessing somatosensory symptoms and included: 1 the performance of the six-category Likert scale; 2 whether a unidimensional construct was defined; 3 the reliability and precision of estimates.
Conclusion The results support that the PDQ can be used as a classification instrument and assist identification of underlying pain-mechanisms in patients suffering from inflammatory arthritis. Background Rheumatoid arthritis RA , psoriatic arthritis PsA and spondyloarthritis SpA are considered systemic inflammatory rheumatic diseases that cause joint destruction, disability and pain.
The traditional approach to pain management has focused on treatment of the underlying disease using anti-inflammatory, disease-modifying drugs [ 1 , 2 ]. However, in some patients, pain does not improve despite seemingly good inflammatory control [ 3 , 4 , 5 , 6 , 7 ]. This suggests that although peripheral tissue inflammation significantly contributes to nociceptive pain generation in inflammatory arthritis [ 8 ], augmented central pain-processing may play a prominent role in persistent pain [ 6 ].
Thus, there is a need for instruments that can assist in identifying patients with augmented central pain mechanisms and thereby help tailor an effective, individualised treatment. To the best of our knowledge no instruments have been developed specifically to assist in mechanisms-based pain classification of patients with inflammatory joint disorders.
It assigns a score to the patients, which classifies pain into three groups: neuropathic, unclear or non-neuropathic nociceptive pain. Neuropathic pain is characterized by allodynia, hyperalgesia, dysesthesia and sudden pain; somatosensory symptoms assessed by the PDQ [ 10 ]. Emerging evidence supports that there are striking pain phenotypic similarities between neuropathic pain and pain conditions characterised by augmented central pain processing; that is how patients express their symptoms of abnormal sensory perceptions and the quality of their pain [ 11 ].
Based on this overlap, the PDQ has been used as indicator of augmented central pain processing in patients with osteoarthritis and fibromyalgia [ 12 , 13 , 14 , 15 ] and recently, the PDQ has been introduced in studies of pain mechanisms in patients with RA [ 16 , 17 ] and SpA [ 18 ]. Satisfactory psychometric properties of the PDQ have been demonstrated within osteoarthritis [ 19 ]. However, they remain to be evaluated within inflammatory arthritis and it is well-established that the psychometric properties of a questionnaire may vary depending on the population it is used in [ 20 ].
Because the PDQ is gaining ground as pain phenotyping instrument within these diagnoses, the psychometric properties, should be investigated as a prerequisite to implementing the PDQ in clinical research or daily practice, in order to secure valid and reliable pain classification of these particular patients. Rasch analysis has traditionally been applied to questionnaires to evaluate a hierarchy of the items e.
Furthermore, Rasch analysis includes a mathematical reliability measure describing how well an instrument differentiates between groups; patients with different pain phenotypes. Finally, large variation in the examined population e. Whether an instrument has reliable classification ability, can be further investigated by test-retest, which will give an estimation of the stability [ 20 ].
Pain phenotypes are as such not expected to alter, thus the classification thereof should be consistent. Estimation of intraclass correlation coefficients based on exact scores can further support reliablity. Specifically, to conduct Rasch analysis, including reliability analysis of pain classification by means of person and item distinction in a sample of patients representing all diagnoses, both genders and every degree of activity of the disease.
Further, to explore the agreement of scores and the stability of pain classification by test-retest. The registry also includes data on patients treated with synthetic disease-modifying antirheumatic drugs DMARDs. Participants who were experiencing nerve pain, also had significantly higher levels of depression, fatigue and disability. The researchers suggest that treatment of the pain should take these other factors into account, to help improve overall wellbeing.
Background Pain is a common symptom in MS and may have several causes. Nerve neuropathic pain is caused by damage to the nerves in the brain and spinal cord.
Examples of nerve pain include trigeminal neuralgia, the MS hug, Lhermitte's sign and altered sensations such as pins and needles, numbness, crawling or burning feelings. This study examined how common nerve pain was in early MS. How this study was carried out people with MS who attended a clinic in Germany took part in the study.
Participants' average age was 36 years old, they had an average EDSS score of 1. This is a survey that was specifically developed to detect nerve pain and has been used in the past for studies into pain in several health conditions including MS.
The questionnaire contains questions about how severe the pain is, where it is, how it feels and if it is made worse by contact such as touching.